EXECUTIVE OVERVIEW
The following analysis of our consolidated financial condition and results of
operations for the six-month period ended
Overview
We expanded our product line in 2002 to include a concealed weapons detection system we call ViewScan. In 2003 we added a hazardous material first response wireless video transmitting system to our product line we refer to as Visual First Responder. Unfortunately, the rising costs of manufacturing equipment and the large quantities required to become cost competitive has forced us to quit manufacturing our own products.
In the short term, management continues to raise funds by providing parts and repair service work to our current installations.
Our strategy for remainder of 2020 is 1: to patent an enhanced and more complex
Weapons Detection Portal. 2: Create a subsidiary that contains all security
related technologies, patents, and expertise to further capitalize in the
security market with superior products 3: utilize the current
The two divisions will continue forward as independently operated entities due to the very different nature of its products and operations.
Products and Services
Our current products and services include:
ViewScan Concealed Weapons Detection System
ViewScan, which has also been sold under the name "Secure Scan", is a walk-through concealed weapons detector which uses magnetic data sensing technology to accurately pinpoint the location, size and number of concealed weapons. This walk-through portal is controlled by a master processing board and a personal computer based unit which receives magnetic and video information and combines it in a manner that allows the suspected locations of the concealed weapon(s) to be displayed and stored electronically.
19 RESULTS OF OPERATIONS
The following discussions are based on our consolidated financial statements,
including our subsidiaries. These charts and discussions summarize our financial
statements for the three months ended
SUMMARY COMPARISON OF OPERATING RESULTS* Three months ended June 30, 2020 2019 Revenues, net $ - $ 700 Cost of sales - - Gross profit (loss) - 700 Total operating expenses 70,630 12,318 Profit (Loss) from operations of continuing operations (70,630 ) (11,618 ) Total other income (expense) (1,626,610 ) (115,668 ) Net income (loss) (1,697,240 ) (127,286 ) Net income (loss) per share $ (0.00 )$ (0.00 )
Three Month Period Ended
Our net loss for the three-month period ended
We have experienced zero sales of our services and products which resulted in
zero revenues for the three month period ended
20
Cost of service provided and the goods sold have been non-existent resulting in
zero profit for the three month period ended
During the three month period ended
Operating expenses incurred during the three-month period ended
Our net operating loss for the continuing operations during the three-month
period ended
During the three-month period ended
During the three-month period ended
After deducting other expense, we realized a net loss of (
The weighted average number of shares outstanding was 1,193,884,558 for the
three-month period ended
LIQUIDITY AND CAPITAL RESOURCES
Six Month Period Ended
As of
As of
Stockholders' deficit increased from (
Cash Flows from Operating Activities
For the six-month period ended
21
Cash Flows from Investing Activities
For the six-month periods ended
Cash Flows from Financing Activities
We have financed our operations primarily from debt or the issuance of equity
instruments. For the six-month period ended
PLAN OF OPERATION AND FUNDING
We have incurred losses for the past two fiscal years and had a net loss of
Our Board of Directors has decided to broaden our perspective and add additional business unrelated to the current security product market. The Board has decided to separate the operation into one focusing on further security products development and one to investigate the medical marijuana business. We plan to separate the two product lines into two separate companies to be able to focus on them individualy.
Going Concern
If the market price of our common stock falls below the fixed price of our registered stock offering, as in prior years we may again have insufficient financing commitments in place to meet our expected cash requirements for 2020 and 2021. We cannot assure you that we will be able to obtain financing on favorable terms. If we cannot obtain financing to fund our operations in 2020 and 20221, then we may be required to reduce our expenses and scale back our operations. These factors raise substantial doubt of our ability to continue as a going concern. Footnote 2 to our financial statements provides additional explanation of Management's views on our status as a going concern. The audited financial statements contained in this Quarterly Report do not include any adjustments to reflect the possible future effects on the recoverability of assets or the amounts of liabilities that may result should we be unable to continue as a going concern.
Our independent registered accounting firm included an explanatory paragraph in their reports on the accompanying financial statements regarding concerns about our ability to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that lead to this disclosure by our independent auditors.
22
COMMITMENTS AND CONTINGENT LIABILITIES
Our total current liabilities increased to
We are in default of the following Promissory notes:
Notes payable as of
2020 2019 Demand loan payable with interest at 5% per month datedSeptember 18, 2009 . The loan is secured by the Company's accounts receivable. The note was payable in full onDecember 17, 2009 and is currently in default.$ 50,000 $ 50,000 Convertible promissory note with interest as 8% per year datedJanuary 24, 2018 , convertible into the Company's common stock 50% discount to the lowest trading price during 25 trading days immediately preceding conversion. The note was due October 24, 2018 and is currently in default - 16,831 Convertible promissory note with interest as 8% per year datedJuly 2, 2018 , convertible into the Company's common stock 50% discount to the lowest trading price during 25 trading days immediately preceding conversion. The note was dueJuly 2, 2019 and is currently in default 40,000 40,000 Convertible promissory note with interest as 8% per year datedAugust 19, 2019 , convertible into the Company's common stock 50% discount to the lowest trading price during 25 trading days immediately preceding conversion. The note is due August 19, 2020 - 38,000 Convertible promissory note with interest as 10% per year datedOctober 8, 2019 , convertible into the Company's common stock 50% discount to the lowest trading price during 25 trading days immediately preceding conversion. The note is due October 20, 2020. 50,000 50,000 Convertible promissory note with interest at 8% per year datedJanuary 8, 2020 , convertible into the Company's common stock 50% discount to the lowest trading price during 25 trading days Immediately preceding the conversion. The note is due January 8, 2021 112,750 - Convertible promissory note with interest as 8% per year datedOctober 22, 2019 , convertible into the Company's common stock 50% discount to the lowest trading price during 25 trading days immediately preceding conversion. The note is due October 22, 2020 5,500 53,000$ 258,250 $ 247,831 Discount on convertible notes (55,157 ) (105,410 )$ 203,093 $ 142,421
OFF BALANCE SHEET ARRANGEMENTS
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
CONTRACTUAL OBLIGATIONS
As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.
CRITICAL ACCOUNTING POLICIES
In all cases revenue is considered earned when the product is shipped to the customer, installed (if necessary) and accepted by the customer as a completed sale.
23 Going Concern Opinion
You should carefully consider the risks, uncertainties and other factors
identified below because they could materially and adversely affect our
business, financial condition, operating results and prospects and could
negatively affect the market price of our Common Stock. Also, you should be
aware that the risks and uncertainties described below are not the only ones
facing us. Additional risks and uncertainties that we do not yet know of, or
that we currently believe are immaterial, may also impair our business
operations and financial results. Our business, financial condition or results
of operations could be harmed by any of these risks. The trading price of our
Common Stock could decline due to any of these risks, and you may lose all or
part of your investment. In assessing these risks you should also refer to the
information contained in or incorporated by reference to our Form 10-K for the
year ended
© Edgar Online, source